Add BrightSurf on Google Email

American Society of Nephrology


Investigational treatment may restore kidney function in renovascular disease patients

A new treatment using vascular endothelial growth factor fused to a bioengineered carrier promotes the recovery of kidney function in pigs with chronic renovascular disease. The study shows that this treatment can improve kidney function, potentially leading to substantial implications for the management of renovascular disease.

SourceAmerican Society of Nephrology·JournalJournal of the American Society of Nephrology·DateNov 5, 2015

Antibodies in the blood provide clues to transplant recipients' likelihood of rejection

Study finds that certain IgG3 and IgG4 donor-specific HLA antibodies correlate with distinct patterns of antibody-mediated injury to transplanted organs. Patients with mostly IgG3 antibodies have a higher likelihood of organ rejection soon after transplantation, while those with mostly IgG4 antibodies experience delayed rejection.

SourceAmerican Society of Nephrology·JournalJournal of the American Society of Nephrology·DateAug 20, 2015

New high-throughput screening method may uncover novel treatments for kidney disease

A new assay developed by researchers can identify novel drug candidates that protect kidney cells from damage, which could lead to the development of new treatments for chronic kidney disease. The system has already identified a small molecule called pyrintegrin that effectively protected rodent kidney cells.

SourceAmerican Society of Nephrology·JournalJournal of the American Society of Nephrology·DateApr 9, 2015